| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial
|
Hervik, Jill
|
|
2008
|
116 |
2 |
p. 311-316
|
article
|
| 2 |
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease
|
Rohan, Thomas E.
|
|
2008
|
116 |
2 |
p. 339-350
|
article
|
| 3 |
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
|
Ellis, Matthew J.
|
|
2008
|
116 |
2 |
p. 371-378
|
article
|
| 4 |
A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow
|
Tjensvoll, Kjersti
|
|
2008
|
116 |
2 |
p. 329-338
|
article
|
| 5 |
Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women
|
Fehringer, Gordon
|
|
2008
|
116 |
2 |
p. 413-423
|
article
|
| 6 |
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research
|
Neuhausen, Susan L.
|
|
2008
|
116 |
2 |
p. 379-386
|
article
|
| 7 |
CHEK2 1100delC and male breast cancer in the Netherlands
|
Wasielewski, Marijke
|
|
2008
|
116 |
2 |
p. 397-400
|
article
|
| 8 |
Complementary and alternative therapies among very long-term breast cancer survivors
|
Carpenter, C. L.
|
|
2008
|
116 |
2 |
p. 387-396
|
article
|
| 9 |
Dietary isoflavone intake and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians
|
Iwasaki, Motoki
|
|
2008
|
116 |
2 |
p. 401-411
|
article
|
| 10 |
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer
|
Jansen, Maurice P. H. M.
|
|
2008
|
116 |
2 |
p. 263-271
|
article
|
| 11 |
Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal–epithelial interactions
|
Pontiggia, Osvaldo
|
|
2008
|
116 |
2 |
p. 247-255
|
article
|
| 12 |
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
|
Thibodeaux, Clare A.
|
|
2008
|
116 |
2 |
p. 281-294
|
article
|
| 13 |
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
|
Colleoni, Marco
|
|
2008
|
116 |
2 |
p. 359-369
|
article
|
| 14 |
Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
|
Viale, Giuseppe
|
|
2008
|
116 |
2 |
p. 317-328
|
article
|
| 15 |
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial
|
Barco, S. Del
|
|
2008
|
116 |
2 |
p. 351-358
|
article
|
| 16 |
The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review
|
Peate, Michelle
|
|
2009
|
116 |
2 |
p. 215-223
|
article
|
| 17 |
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
|
Mook, Stella
|
|
2008
|
116 |
2 |
p. 295-302
|
article
|
| 18 |
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
|
Zhang, Yi
|
|
2008
|
116 |
2 |
p. 303-309
|
article
|
| 19 |
The hedgehog pathway as a therapeutic target for treatment of breast cancer
|
Barginear, M. F.
|
|
2009
|
116 |
2 |
p. 239-246
|
article
|
| 20 |
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer
|
Lahusen, Tyler
|
|
2009
|
116 |
2 |
p. 225-237
|
article
|
| 21 |
Three-dimensional pathological size assessment in primary breast carcinoma
|
Güth, Uwe
|
|
2008
|
116 |
2 |
p. 257-262
|
article
|
| 22 |
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition
|
Köster, Frank
|
|
2008
|
116 |
2 |
p. 273-279
|
article
|
Journal description